Treatment of obsessive-compulsive disorder using clomipramine in a very old patient

被引:3
作者
Trappler, B [1 ]
机构
[1] SUNY Hlth Sci Ctr, Dept Psychiat, Brooklyn, NY 11203 USA
关键词
Alzheimer disease; obsessive-compulsive disorder; fluoxetine; clomipramine;
D O I
10.1345/aph.18193
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To describe the effect of the tricyclic drug clomipramine in a very old patient with obsessive-compulsive disorder and Alzheimer dementia. CASE SUMMARY: A 93-year-old woman had a history of obsessive-compulsive disorder since early adulthood. The obsession consisted of remembering names of famous people and the compulsion consisted of excessive list making. With the onset of memory loss secondary to Alzheimer disease, she became increasingly anxious and compulsive as a result of a failure to remember. After nine weeks on fluoxetine she became jittery and more confused. After a two-week wash-out period, she was given a nine-week course of clomipramine that was carefully titrated up to a therapeutic concentration. RESULTS: At the completion of clomipramine treatment, the patient no longer felt driven to recall the names of famous people. Her score from the Yale-Brown Obsessive-Compulsive Scale dropped from 29 to 3. Her Folstein Mini-Mental State Examination score increased from 21 to 23. CONCLUSIONS: Clomipramine appeared much more effective and better tolerated than fluoxetine in this very old patient despite its potential anticholinergic effect and the coexistence of Alzheimer disease.
引用
收藏
页码:686 / 690
页数:5
相关论文
共 50 条
  • [21] Anterior capsulotomy for treatment of refractory obsessive-compulsive disorder: Results in a young and an old patient
    Christensen, DD
    Laitinen, LV
    Schmidt, LJ
    Hariz, MI
    STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 2002, 79 (3-4) : 234 - 244
  • [22] CLOMIPRAMINE-INDUCED TOURETTISM IN OBSESSIVE-COMPULSIVE DISORDER - CLINICAL AND THEORETICAL IMPLICATIONS
    KOTLER, M
    IANCU, I
    KINDLER, S
    LEFKIFKER, E
    ZOHAR, J
    CLINICAL NEUROPHARMACOLOGY, 1994, 17 (04) : 338 - 343
  • [23] EARLY RESPONSE WITH CLOMIPRAMINE IN OBSESSIVE-COMPULSIVE DISORDER - A PLACEBO CONTROLLED-STUDY
    MONTGOMERY, SA
    MONTGOMERY, DB
    FINEBERG, N
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1990, 14 (05) : 719 - 727
  • [24] Adequacy of treatment in outpatients with obsessive-compulsive disorder
    Cohen, S. E.
    Storosum, B. W.
    Vulink, N. C.
    De Koning, P. P.
    Namavar, Y.
    Zantvoord, J. B.
    Denys, D.
    COMPREHENSIVE PSYCHIATRY, 2025, 136
  • [25] A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder
    Bisserbe, JC
    Lane, RM
    Flament, MF
    vanMoffaert, M
    Magerman, J
    Ansart, E
    Danan, A
    Bensoussan, M
    Faure, M
    Hantz, D
    Apse, G
    Louboff, F
    Guilbert, P
    Hantouche, E
    LeGoubey, P
    Rigaud, M
    Lenouene, MC
    Durand, MFM
    Barrere, J
    deMondragon, M
    Deroche, D
    Leclercq, P
    Blauwblomme, JF
    Denis, E
    Singer, P
    Vallee, D
    Meynard, J
    Wiseman, R
    Goldberg, M
    Calderon, I
    EUROPEAN PSYCHIATRY, 1997, 12 (02) : 82 - 93
  • [26] Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine
    Mundo, E
    Rouillon, F
    Figuera, ML
    Stigler, M
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2001, 16 (06) : 461 - 468
  • [28] Pharmacological Treatment of Obsessive-Compulsive Disorder
    Pittenger, Christopher
    Bloch, Michael H.
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2014, 37 (03) : 375 - +
  • [29] Nicotine treatment of obsessive-compulsive disorder
    Lundberg, S
    Carlsson, A
    Norfeldt, P
    Carlsson, ML
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2004, 28 (07) : 1195 - 1199
  • [30] The Pharmacological Treatment of Obsessive-Compulsive Disorder
    Pittenger, Christopher
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2023, 46 (01) : 107 - 119